STEMI (ST ELEVATION MI)
Clinical trials for STEMI (ST ELEVATION MI) explained in plain language.
Never miss a new study
Get alerted when new STEMI (ST ELEVATION MI) trials appear
Sign up with your email to follow new studies for STEMI (ST ELEVATION MI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart attack patients may soon skip aspirin: new trial tests safer drug combo
Disease control Recruiting nowThis study tests whether using only ticagrelor (a blood thinner) after a heart attack can reduce bleeding risks compared to the standard combination of aspirin and ticagrelor. About 2,570 adults who had a heart attack but did not receive stents or bypass surgery will be followed …
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated May 17, 2026 06:51 UTC
-
New drug aims to limit heart damage after attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe type of heart attack (STEMI) and are getting a procedure to open the blocked artery. Participants receive either Xolatryp or a placebo as a one-time IV infusion over 6 hours. The study checks if the drug …
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
Heart attack drug trial aims to save tiny vessels
Disease control Recruiting nowThis study tests if the drug Ranolazine can help protect the tiny blood vessels in the heart after a major heart attack. About 100 adults who have had a heart attack and have blockages in more than one artery will receive either standard care or standard care plus Ranolazine. The…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2, PHASE3 • Sponsor: Federico II University • Aim: Disease control
Last updated May 14, 2026 12:03 UTC